# Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers

> **NCT03137966** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Karolinska University Hospital** · enrollment: 174 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Deferoxamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03137966
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-12-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03137966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03137966, "Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03137966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*